[ad_1]
Certain medications prescribed by doctors could cost more from January 2019. In question, a reform of 2017 which will partly come into force on this date and which concerns the "dispensing fees" perceived by the pharmacists, report our confreres Parisian.
These fees will be put in place to offset the decrease in their margin with the forced drop in the price of refundable drugs.
Pharmacists currently receive 1.02 euros for each sale of prescription treatment.
This fixed sum is borne by the Social Security for two thirds and by the additional for the remaining part. But not for long.
However, in 2019, this fee will depend on the drug sold by the pharmacist, and will no longer be universal. The daily takes the example of the sleeping drug Stilnox, whose fee will rise for example to 4.08 euros for a box of 14 tablets marketed at the price of 3.09 euros for a patient under 70 years.
"We will create a new dependent"
Supplementary insurances may no longer cover one third of this amount, as they did before.
In addition to the possible amount not reimbursed by the Social Security, patients should also pay the pharmacist a portion of the dispensing fee (in this case, 1.36 euro).
"We will create a new dependent at the moment when we try to delete them!"Philippe Gaertner, president of the FSPF (Federation of Pharmaceutical Trade Unions in France), asked Le Parisien.
Paradoxically, to avoid having to pay these fees, the patient will have every interest in avoiding asking for the reimbursement of his medications to the Health Insurance. Indeed, with the reform, dispensing fees will only apply in the event of a claim for reimbursement.
For Stilnox, the patient will pay less if he buys his treatment without a prescription. He will not have to pay his fees to the pharmacist but will have to pay from his pocket the full cost of the box, or 3.09 euros. And the pharmacist will not touch his fees. Asked by the Parisian, the Health Insurance did not wish to explain on this file.
[ad_2]
Source link